和文(総説著書)はこちら

英文

  1. Amano, R., Aoki, K., Miyakawa, S., Nakamura, Y., Kozu, T., Kawai, G., Sakamoto, T.: NMR monitoring of the SELEX process to confirm enrichment of structured RNA. Sci Rep., 7(1):283 (2017)
  2. Goto, R., Miyakawa, S., Inomata, E., Shioyama, S., Nishida, Y., Yamaura, J., Nakamura, Y.: De novo sequencing of highly modified therapeutic oligonucleotides by hydrophobic tag sequencing coupled with LC-MS. J Mass Spectrom., 52(2):78–93 (2017)
  3. Hashimoto, Y., Takahashi, M., Sakota, E., Nakamura, Y.: Nonstop-mRNA decay machinery is involved in the clearance of mRNA 5'-fragments produced by RNAi and NMD in Drosophila melanogaster cells. Biochem Biophys Res Commun., 484(1):1-7 (2017)
  4. Jaafar, ZA., Oguro, A., Nakamura, Y., Kieft, JS.: Translation initiation by the hepatitis C virus IRES requires eIF1A and ribosomal complex remodeling. Elife, 5.pii:e21198 (2016)
  5. Amano, R., Takada, K., Tanaka, Y., Nakamura, Y., Kawai, G., Kozu, T., Sakamoto, T.:Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein. Biochemistry, 55(45):6221-6229 (2016)
  6. Imashimizu, M., Afek, A., Takahashi, H., Lubkowska, L., and Lukatsky, D. B.: Control of transcriptional pausing by biased thermal fluctuations on repetitive genomic sequences. PNAS, 113(47):E7409-E7417 (2016)
  7. Takahashi, M., Sakota, E., Nakamura, Y.: The efficient cell-SELEX strategy, Icell-SELEX, using isogenic cell lines for selection and counter-selection to generate RNA aptamers to cell surface proteins. Biochimie, 131: 77-84 (2016)
  8. Jin, L., Nonaka, Y., Miyakawa, S., Fujiwara, M., Nakamura, Y.: Dual therapeutic action of a neutralizing anti-FGF2 aptamer in bone diseases and bone cancer pain. Mol. Ther., 24(11):1974-1986 (2016)
  9. Takahashi, M., Fukuoka, M., Yoshioka, K., Hohjoh, H.: Neighbors' death is required for surviving human adenocarcinoma PC-9 cells in an early stage of gefitinib treatment. Biochem Biophys Res Commun., 479(2):393-397 (2016)
  10. Kato, K., Ikeda, H., Miyakawa, S., Futakawa, S., Nonaka, Y., Fujiwara, M., Aoki, J., Morita, J., Ishitani, R., Nishimasu, H., Nakamura, Y., Nureki, O.: Structural basis for specific inhibition of Autotaxin by a DNA aptamer. Nature Struct. Mol. Biol., 23: 395-401 (2016)
  11. Takahashi, M., Suzuki, M., Fukuoka, M., Fujikake, N., Watanabe, S., Murata, M., Wada, K., Nagai, Y., Hohjoh, H.: Normalization of overexpressed alpha-synuclein causing Parkinson’s disease by a moderate gene silencing with RNA interference. Mol. Ther. Nucleic Acids, 12;4:e241 (2015)
  12. Hashimoto, Y., Inagaki, H., Hoshino, S.: Calpain mediates processing of the translation termination factor eRF3 into the IAP-binding isoform p-eRF3. FEBS Lett, 589: 2241-2247 (2015)
  13. Kashima, I., Takahashi, M., Hashimoto, Y., Sakota, E., Nakamura, Y., Inada, T.: A functional involvement of ABCE1, eukaryotic ribosome recycling factor, in nonstop mRNA decay in Drosophila melanogaster cells. Biochimie, 106: 10-16 (2014)
  14. Takahashi, M., Hohjoh, H.: A novel measurement of allele discrimination for assessment of allele-specific silencing by RNA interference. Mol Biol Rep, 41(11):7115-20 (2014)
  15. Fukuoka, M., Yoshida, M., Eda, A., Takahashi, M., Hohjoh, H.: Gene silencing mediated by endogenous microRNAs under heat stress conditions in mammalian cells. PLoS One, 9(7):e103130 (2014)
  16. Arai, C., Kurahashi, H., Pack, C.-G., Sako, Y., Nakamura, Y.: Clearance of yeast eRF-3 prion [PSI+] by amyloid enlargement due to the imbalance between chaperone Ssa1 and cochaperone Sgt2. Translation, 1(2): e26574 (2013)
  17. Nomura, Y., Tanaka, Y., Fukunaga, J., Fujiwara, K., Chiba, M., Iibuchi, H., Tanaka, T., Nakamura, Y., Kawai, G., Kozu,T., Sakamoto, T.: Solution structure of a DNA mimicking motif of an RNA aptamer against transcription factor AML1 Runt domain. J Biochem, 154: 513-519 (2013)
  18. Soeno, Y., Fujita, K., Kudo, T., Asagiri, M., Kakuta, S., Taya, Y., Shimazu, Y., Sato, K., Kubo, S., Iwakura, Y.,Nakamura, Y., Aoba, T.:Generation of a mouse model with down-regulated U50 snoRNA (SNORD50) expression and its organ-specific phenotypic modulation. PLoS One, 8: e72105 (2013)
  19. Kishida, S., Ping, M., Miyakawa, S., Fujiwara, M., Abe, T., Sakamoto, K., Onishi, A., Nakamura, Y., Kadomatsu, K.:Midkine promotes neuroblastoma through Notch2 signaling. Cancer Res, 73: 1318-1327(2013)
  20. Arai, C., Kurahashi, H., Ishiwata, M., Oishi, K., Y., Nakamura, Y.: Clearance of yeast prions by misfolded multi-transmembrane proteins. Biochimie, 95: 1223-1232 (2013)
  21. Ohuchi, S., Shibuya, M., Nakamura, Y.: The RNA aptamer inhibiting human vesicular endothelial growth factor receptor 1 without affecting the cytokine binding. Biochemistry, 52: 2274-2279 (2013)
  22. Fukunaga, J., Nomura, Y., Tanaka, Y., Tanaka, T., Nakamura, Y., Kawai, G., Sakamoto, T., Kozu, T.: The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element. RNA, 19: 927-936 (2013)
  23. Oishi, K., Kurahashi, H., Pack, C-G., Sako, Y., Nakamura, Y.:A bipolar functionality of Q/N-rich proteins: Lsm4 amyloid causes clearance ofyeast prions.MicrobiologyOpen, 2: 415-430 (2013)
  24. Nakamura, Y., Ishiguro, A., Miyakawa, S.: RNA plasticity and selectivity applicable to therapeutics and novel biosensor development. Genes to Cells, 17: 344-364 (2012)
  25. Fujimoto, Y., Nakamura, Y., Ohuchi, S.P.: HEXIM1 binding elements on mRNAs identified through transcriptomic SELEX and computational screening. Biochimie, 94: 1900-1909 (2012)
  26. Mori, Y., Nakamura, Y., Ohuchi, S.P.: Inhibitory RNA aptamer against SP6 RNA polymerase. Biochem. Biophys. Res. Commun.,420: 440-443 (2012)
  27. Ohuchi, S., Mori, Y., Nakamura, Y.: Evolution of an inhibitory RNA aptamer against T7 RNA polymerase. FEBS Open Bio, 2:203-207 (2012)
  28. Nakamura, Y., Ito, K.: tRNA mimicry in translation termination and beyond. Wiley Interdiscip. Rev. RNA, 2: 647-668 (2012)
  29. Iwagawa, T., Ohuchi, S.P., Watanabe, S., Nakamura, Y.: Selection of RNA aptamers against mouse embryonic stem cells. Biochimie, 94: 250-257 (2012)
  30. Kurahashi, H., Oishi, K., Nakamura, Y.: A bipolar personality of yeast prion proteins, Prion, 5: 305-310 (2011)
  31. Ishiguro, A., Akiyama, T., Adachi, H., Inoue, J., Nakamura, Y.: Therapeutic potential of anti-interleukin-17A aptamer:suppression of IL-17A signaling and attenuation of autoimmunity in mouse models. Arthritis Rheum., 63: 455-466 (2011)
  32. Kurahashi, H., Pack, C., Shibata, S., Oishi, K., Sako, Y., Nakamura, Y.: [PSI+] aggregate enlargement in rnq1 non-prion domain mutants, leading to a loss-of-prion in yeast. Genes Cells, 16: 576-589 (2011)
  33. Nakamura, Y.: Aptamer: Biology to Applications. Adv. Polym. Sci., 249: 135-152 (2011)
  34. Adachi, H., Ishiguro, A., Hamada, M., Sakota, E., Asai, K., Nakamura, Y.: Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A/F. Biochimie, 93: 1081-1088 (2011)
  35. Endo, K., Nakamura, Y.: A binary Cy3 aptamer probe composed of folded modules. Anal. Biochem, 400: 103-109 (2010)
  36. Watanabe, Y., Nakamura, Y., Ito, K.: A novel class of bacterial translation factor RF3 mutations suggests specific structural domains for premature peptidyl-tRNA drop-off. FEBS Lett., 584: 790-794 (2010)
  37. Hiep, H.M., Saito, M., Nakamura, Y., Tamiya, E.: RNA aptamer-based optical nanostructured sensor for highly sensitive and label-free detection of antigen-antibody reactions. Anal. Bioanal. Chem., 396(7): 2575-2581 (2010)
  38. Nomura, Y., Sugiyama, S., Sakamoto, T., Miyakawa, S., Adachi, H., Takano, K., Murakami, S., Inoue, T., Mori, Y.,Nakamura, Y.*, Matsumura, H.* (co-correspondence): Conformational plasticity of RNA for target recognition as revealed by the 2.15 Å crystal structure of a human IgG-aptamer complex. Nucl. Acids Res., 38: 7822-7829 (2010)
  39. Shibata, S., Kurahashi, H., Nakamura, Y.: Localization of prion-destabilizing mutations in the N-terminal non-prion domain of Rnq1 in Saccharomyces cerevisiae. Prion, 3: 250-258 (2009)
  40. Nakamura, Y., Endo, K., Adachi, H., Ishiguro, A.: RNA Aptamers to Translational Components. In: Hershey J.W.B., ed.Translational Control in Health and Disease. Elsevier Press, pp. 369-395 (2009)
  41. Cheng, Z., Saito, K., Pisarev, A. V., Wada, M., Pisareva, V. P., Pestova, T. V., Gajda, M., Round, A., Kong, C., Lim, M.,Nakamura, Y., Svergun, D. I., Ito, K., Song, H.: Structural insights into eRF3 and stop codon recognition by eRF1. Genes Dev, 23: 1106-1118 (2009)
  42. Kurahashi, H., Shibata, S., Ishiwata, M., Nakamura, Y.: Selfish prion of Rnq1 mutant in yeast. Genes Cells, 14: 659-668 (2009)
  43. Oguro, A., Ohtsu, T., Nakamura, Y.: An aptamer-based biosensor for mammalian initiation factor eukaryotic initiation factor 4A. Anal. Biochem, 388: 102-107 (2009)
  44. Ishiwata, M., Kurahashi, H., Nakamura, Y.: A G-protein gamma subunit mimic is a general antagonist of prion propagation in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA, 106: 791-796 (2009)
  45. Sugiyama, S., Nomura, Y., Sakamoto, T., Kitatani, T., Kobayashi, A., Miyakawa, S., Takahashi, Y., Adachi, H., Takano, K., Murakami, S., Inoue, T., Mori, Y., Nakamura, Y., Matsumura, H.: Crystallization and preliminary X-ray diffraction studies of an RNA aptamer in complex with the human IgG Fc fragment. Acta Crystallographica, F64: 942-944 (2008)
  46. Ohuchi, S.P., Ikawa, Y., Nakamura, Y.: Selection of a novel class of RNA-RNA interaction motifs based on the ligase ribozyme with defined modular architecture. Nucl. Acids Res., 36: 3600-3607 (2008)
  47. Miyakawa, S., Nomura, Y., Sakamoto, T., Yamaguchi, Y., Kato, K., Yamazaki, S., Nakamura, Y.: Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G. RNA, 14: 1154-1163 (2008)
  48. Kurahashi, H., Ishiwata, M., Shibata, S., Nakamura, Y.: A regulatory role of the Rnq1 non-prion domain for prion propagation and polyglutamine aggregates. Mol. Cell. Biol., 28: 3313-3323 (2008)
  49. Wang, J., Takeuchi, H., Jin, S., Sonobe, Y., Shijie, J., Mizuno, T., Miyakawa, S., Fujiwara, M., Nakamura, Y., Kato, T., Muramatsu, H., Muramatsu, T., Suzumura, A.: Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc. Natl. Acad. Sci. USA, 105: 3915-3920 (2008)
  50. Ohuchi, S.P., Nakamura, Y.: Slight sequence modifications unexpectedly alter the metal dependency of a kissing-loop interaction. Nucl. Acids Symp. Series, 51: 395-396 (2007)
  51. Ehrenberg, M., Hauryliuk, V., Crist, C.G., Nakamura, Y.: Translation Termination, the Prion [PSI+], and Ribosomal Recycling. In: Mathews, M.B., Sonenberg, N., Hershey, J.W.B., eds. Translational Control in Biology and Medicine. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, pp. 173-196 (2007)
  52. Tanaka, Y., Akagi, K., Nakamura, Y., Kozu, T.: RNA aptamers targeting the C-terminal of KRAS oncoprotein generated by an improved SELEX with isothermal RNA amplification. Oligonucleotides, 17: 12-21 (2007)
  53. Tanaka-Fujita, R., Soeno, Y., Satoh, H., Nakamura, Y., Mori, S.: Human and mouse protein non-coding snoRNA host genes with dissimilar nucleotide sequences show chromosomal synteny. RNA, 13: 811-816 (2007)
  54. Li, X., Yokota, T., Ito, K., Nakamura, Y., Aiba, H.: Reduced activity or expression of polypeptide release factors induces mRNA cleavage and tmRNA tagging at stop codons in E. coli. Mol. Microbiol., 63: 116-126 (2007)
  55. Kurahashi, H., Nakamura, Y.: Channel mutations in Hsp104 hexamer distinctively affect thermotolerance and prion-specific propagation. Mol. Microbiol., 63: 1669-1683 (2007)
  56. Kodama, H., Ito, K., Nakamura, Y.: The role of N-terminal domain of translational release factor eRF3 for the control of functionality and stability in S. cerevisiae. Genes Cells, 12: 639-650 (2007)
  57. Takahashi, A., Hara, H., Kurahashi, H., Nakamura, Y.: A Systematic Evaluation of the Function of the Protein-Remodeling Factor Hsp104 in [PSI+] Prion Propagation in S. cerevisiae by Comprehensive Chromosomal Mutations. Prion, 1: 69-77 (2007)
  58. Crist, C.G., Kurahashi, H., Nakayashiki, T., Nakamura, Y.: Conformation preserved in a weak-to-strong or strong-to-weak [PSI+] conversion during transmission to Sup35 prion variants. Biochimie, 88: 485-496 (2006)
  59. Sato, H., Ito, K., Nakamura, Y.: Ribosomal protein L11 mutations in two functional domains equally affect release factor 1 and 2 activity. Mol. Microbiol., 60: 108-120 (2006)
  60. Ohuchi, S.P., Ohtsu, T., Nakamura, Y.: Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface. Biochimie, 88: 897-904 (2006)
  61. Crist, C.G., Nakamura, Y.: Cross-talk between RNA and prions. J. Biochem. (Tokyo), 140:167-173 (2006)
  62. Miyakawa, S., Oguro, A., Ohtsu, T., Imataka, H., Sonenberg, N., Nakamura, Y.: RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes. RNA, 12:1825-1834 (2006)
  63. Ohuchi, S.P., Ohtsu, T., Nakamura, Y.: A novel method to generate aptamers against recombinant targets displayed on the cell surface. Nucl. Acids Symp. Series, 49: 351-352 (2005)
  64. Mochizuki, K., Oguro, A., Ohtsu, T., Sonenberg, N., Nakamura, Y.: High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation. RNA, 11: 77-89 (2005)
  65. Sakamoto, T., Oguro, A., Kawai, G., Sonenberg, N., Ohtsu, T., Nakamura, Y.: NMR structures of double loops of an RNA aptamer against mammalian initiation factor 4A (ISSUE COVER selected). Nucl. Acids Res., 33: 745-754 (2005)
  66. Kong, C., Ito, K., Walsh, M., Wada, M., Liu, Y., Kumar, S., Barford, D., Nakamura, Y., Song, H.: Crystal Structure and Functional Analysis of the Eukaryotic Class II Release Factor eRF3 from S. Pombe. Mol. Cell, 14: 233-245 (2004)
  67. Fujiwara, T., Ito, K., Yamami, T., Nakamura, Y.: Ribosome recycling factor disassembles the posttermination ribosomal complex independent of the ribosomal translocase activity of elongation factor G. Mol. Microbiol., 53:517-28 (2004)
  68. Yamami, T., Ito, K., Fujiwara, T., Nakamura, Y.: Heterologous expression of Aquifex aeolicus ribosome recycling factor in Escherichia coli is dominant lethal by forming a complex that lacks functional coordination for ribosome disassembly. Mol. Microbiol., 55:150-161 (2004)
  69. Karamyshev, A.L., Karamysheva, Z.N., Yamami, T., Ito, K., Nakamura, Y.: Transient idling of posttermination ribosomes ready to reinitiate protein synthesis. Biochimie, 86: 933-938 (2004)
  70. Kasashima, K., Nakamura, Y., Kozu, T.: Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem. Biophys. Res. Commun., 322:403-410 (2004)
  71. Mori, T., Oguro, A., Ohtsu, T., Nakamura, Y.: RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. Nucl. Acids Res., 32: 6120-6128 (2004)
  72. Karamysheva, Z.N., Karamyshev, A.L., Ito, K., Yokogawa, T., Nishikawa, K., Nakamura, Y., Matsufuji, S.: Antizyme frameshifting as a functional probe of eukaryotic translational termination. Nucl. Acids Res., 31: 5949-5956 (2003)
  73. Nakamura, Y., Ito, K.: Making sense of mimic in translation termination. Trends Biochem. Sci., 28: 99-105 (2003)
  74. Polacek, N., Ito, K., Gomez, M., Xiong, L., Nakamura, Y., Mankin, A.: The critical role of the universally conserved nucleotide A2602 of the large ribosomal subunit RNA in the release of the nascent peptide during translation termination. Mol. Cell, 11: 103-112 (2003)
  75. Laursen, B.S., Siwanowicz, I., Larigauderie, G., Hedegaard, J., Ito, K., Nakamura, Y., Kenney, J., Mortensen, K.K., Sperling-Petersen, H.U.: Characterization of mutations in the GTP-binding domain of IF2 resulting in cold-sensitive growth of Escherichia coli. J. Mol. Biol., 326: 543-551 (2003)
  76. Oguro, A., Ohtsu, T., Svitkin, Y. V., Sonenberg, N. and Nakamura, Y.: RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. RNA, 9: 394-407 (2003)
  77. Crist, C.G., Nakayashiki, T., Kurahashi, H., Nakamura, Y.: [PHI+], a novel Sup35-prion variant propagated with non-Gln/Asn oligopeptide repeats in the absence of the chaperone protein Hsp104. Genes Cells, 8: 603-618 (2003)
  78. Karamysheva, Z.N., Karamyshev, A.L., Ito, K., Yokogawa, T., Nishikawa, K., Nakamura, Y., Matsufuji, S.: Antizyme frameshifting as a functional probe of eukaryotic translational termination. Nucl. Acids Res., 31: 5949-5956 (2003)
  79. Hara, H., Nakayashiki, T., Crist, C.G., Nakamura, Y.: Prion domain interaction responsible for species discrimination in yeast [PSI+] transmission. Genes Cells, 8: 925-939 (2003)
  80. Ito, K., Fujiwara, T., Toyoda, T., Nakamura, Y.: Elongation factor G participates in ribosome disassembly by interacting with ribosome recycling factor at their tRNA-mimicry domains. Mol. Cell, 9: 1263-1272 (2002)
  81. Ito, K., Frolova, L., Seit-Nebi, A., Karamyshev, A.L., Kisselev, L., Nakamura, Y.: Omnipotent decoding potential resides in eukaryotic translation termination factor eRF1 of variant-code organisms and is modulated by the interactions of amino acid sequences within the domain 1. Proc. Natl. Acad. Sci. USA, 99: 8494-8499 (2002)
  82. Blake, B.K., Ito, K., Nakamura, Y., Alam, S.: Backbone 1H, 13C, and 15N assignments of the ribosome recycling factor from Thermus thermophilus. J. Biomol. NMR, 24 81-82 (2002)
  83. Uno, M., Ito, K., Nakamura, Y.: Polypeptide release at sense and noncognate stop codons by localized charge-exchange alterations in translational release factors. Proc. Natl. Acad. Sci. USA, 99: 1819-1824 (2002)
  84. Nakamura, Y., Uno, M., Toyoda, T., Fujiwara, T., Ito, K.: Protein tRNA mimicry in translation termination. Cold Spring Harbor Symp. Quant. Biol., 66: 469-475 (2002)
  85. Kervestin, S., Garnier, O.A., Karamyshev, A.L., Ito, K., Nakamura, Y., Meyer, E., Jean-Jean, O.: Isolation and expression of two genes encoding eukaryotic release factor 1 (eRF1) from Paramecium tetraurelia. J. Euk. Microbiol., 49: 374-382 (2002)
  86. Nakamura, Y., Ito, K.: A tripeptide discriminator for stop codon recognition. FEBS Lett., 514: 30-33 (2002)
  87. Nevskaya, N., Tishchenko, S., Paveliev, M., Smolinskaya, Y., Fedorov, R., Piendl, W., Nakamura, Y., Toyoda, T., Garber, M., Nikonov, S.: Structure of ribosomal protein L1 from Methanococcus thermolithotrophicus. Functionally important structural invariants on L1 surface. Acta Cryst., D58: 1023-1029 (2002)
  88. Fujiwara, T., Ito, K., Nakamura, Y.: Functional mapping of the ribosome contact site in the ribosome recycling factor. RNA, 7: 64-70 (2001)
  89. Nakayashiki, T., Ebihara, K., Bannai, H., Nakamura, Y.: Yeast [PSI+] prions that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. Mol. Cell, 7: 1121-1130 (2001)
  90. Nakamura, Y.: Molecular mimicry between protein and tRNA. J. Mol. Evol., 53: 282-289 (2001)
  91. Gong, F., Ito, K., Nakamura, Y., Yanofsky, C.: The mechanism of tryptophan induction of tryptophanase operon expression: Tryptophan inhibits release factor-mediated cleavage of TnaC-peptidyl-tRNAPro. Proc. Natl. Acad. Sci. USA, 98: 8997-9001 (2001)
  92. Ito, K., Uno, M., Nakamura, Y.: A tripeptide 'anticodon' deciphers stop codons in messenger RNA. Nature, 403: 680-684 (2000)
  93. Nakamura, Y., Ito, K., Ehrenberg, M.: Mimicry grasps reality in translation termination. Cell, 101: 349-352 (2000)
  94. Wilson, K., Ito, K., Noller, H., Nakamura, Y.: Functional sites of interaction between release factor RF1 and the ribosome. Nature Structural Biol., 7: 866-870 (2000)
  95. Toyoda, T., Tin, O.F., Ito, K., Fujiwara, T., Kumasaka, T., Yamamoto, M., Garber, M.B., Nakamura, Y.: Crystal structure combined with genetic analysis of the Thermus thermophilus ribosome recycling factor shows that a flexible hinge may act as a functional switch. RNA, 6: 1432-1444 (2000)
  96. Nakamura, Y., Kawazu, Y., Uno, M., Yoshimura, K., Ito, K.: Genetic probes to bacterial release factors: tRNA mimicry hypothesis and beyond. In: The Ribosome: Structure, Function, Antibiotics and Cellular Interactions (Garrett, R. A., Douthwaite, S. R., Liljas, A., Matheson, A. T., Morre, P. B., Noller, H. F., eds.), The American Society for Microbiology, Washington, D.C. pp. 519-526 (2000)
  97. Tanaka, R., Satoh, H., Moriyama, M., Satoh, K., Morishita, Y., Yoshida, S., Watanabe, T., Nakamura, Y., Mori, S.: Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells, 5: 277-287 (2000)
  98. Tin, O.F., Rykunova, A.I., Muranova, T.A., Toyoda, T., Ito, K., Suzuki, T., Watanabe, K., Garber, M.B., and Nakamura, Y.: Proteolytic fragmentation of polypeptide release factor 1 of Thermus thermophilus and crystallization of the stable fragments. Biochimie, 82: 765-772 (2000)
  99. Takahashi, T., Hosoya, N., Endo, T., Nakamura, T., Sakashita, H., Kimura, K., Ohnishi, K., Nakamura, Y., and Iwamoto, A.: Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis Isolates in Japan and resistance to sulfonamide therapy. J. Clin. Microbiol., 38: 3161-3164 (2000)
  100. Hosoya, N., Takahashi, T., Wada, M., Endo, T., Nakamura, T., Sakashita, H., Kimura, K., Ohnishi, K., Nakamura, Y., Mizuochi, T., and Iwamoto, A.: Genotyping of Pneumocystis carinii f. sp. hominis isolates in Japan based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. Microbiol. Immunol., 44: 591-596 (2000)
  101. Ishino, T., Atarashi, K., Uchiyama, S., Yamami, T., Yoshida, T., Hara, H., Yokose, K., Kobayashi, Y., Nakamura, Y.: Interaction of ribosome recycling factor and elongation factor EF-G with E. coli ribosomes studied by surface plasmon resonance technique. Genes Cells, 5: 953-963 (2000)
    

書籍

田原総一朗、中村義一:RNAルネッサンス 遺伝子新革命、医薬経済社(2006)


和文等(総説著書)

  1. 青木一晃、藤原将寿、中村義一:核酸医薬創出に向けた核酸化学研究の進展、「生命現象を観る」(濡木理監修)、医学の歩み、in press (2017)
  2. 阿部智行、宮川伸、中村義一:アプタマーの医薬品化、日本薬理学雑誌、147:362-367(2016)
  3. 二川了次、藤原将寿、中村義一:核酸医薬品の非臨床試験、PHARMSTAGE, 16(7): 19-24 (2016)
  4. 野中洋介、藤原将寿、中村義一:アプタマーを標的とした研究の進展と安全性評価、技術情報協会書籍出版、印刷中(2016)
  5. 藤原将寿、中村義一:アプタマーの創製と医薬開発、核酸医薬の創製と応用展開、シーエムシー出版、113-121(2016)
  6. 宮川伸、中村義一:RNAアプタマー医薬の最近の動向、Medical Science Digest、40: 360-363 (2014)
  7. 松田雄作、中村義一:次世代分子標的薬の研究 核酸医薬、日本臨牀 増刊号「分子標的薬 -がんから他疾患までの治癒をめざして- 」、70巻、増刊号8、393-397 (2012)
  8. 中村義一:特集にあたって、BIO INDUSTRY、Vol.29 No.7 : 3 (2012)
  9. 石黒亮、中村義一:関節炎モデルマウスに対する抗IL-17Aアプタマーの効果、リウマチ科、47: 294-299 (2012)
  10. 石黒亮、中村義一:RNAアプタマーの分子標的への応用、医薬ジャーナル、48: 85-88 (2012)
  11. 山浦順司、中村義一:RNAの造形力と創薬、化学工業、63: 287-294 (2012)
  12. 中村義一:アプタマー医薬品、MEDCHEM NEWS、22 (No.3): 14-19 (2012)
  13. 石黒亮、中村義一: アプタマー(核酸抗体)、「新機能抗体開発ハンドブック」(監修・浜窪隆雄)、双文社 (2012)
  14. 宮川伸、中村義一:アプタマーを用いた抗体精製、「バイオ医薬品製造の効率化と生産基材の開発」(監修・山口照英)、CMC出版、239-246 (2012)
  15. 中村義一:RNAルネッサンスと創薬、医薬品医療機構レギュラトリーサイエンス、42:1016-1019 (2011)
  16. 斎藤和紀、和田美紀、伊藤耕一:リボソームの機能構造研究のビッグバン ー2009年ノーベル化学賞のインパクト、実験医学、28: 1668-1675 (2010)
  17. 石黒亮、石川百合子、中村義一:核酸医薬品ーその原理と応用、日本臨牀増刊号 遺伝子診療学 vol. 68, Suppl 8, 590-594 (2010)
  18. 中村義一:Ribosome world war、蛋白質核酸酵素、1月号、55: 108-113 (2010)
  19. 中村義一:2009年ノーベル化学賞、苦渋の結論、実験医学、12月号、27: 3112-3113 (2009)
  20. 中村義一:RNAの造形力を利用した創薬、現代化学、11月号、No.464、pp.55-61 (2009)
  21. 青木一晃, 石川百合子, 藤原将寿, 宮川伸, 中村義一:RNAアプタマーの分子標的薬への応用、Medical Science Digest、35:578-581 (2009)
  22. 遠藤慧, 中村義一:アプタマー、「かたち」を創る RNA、Cytometry Research、19: 1-7 (2009)
  23. 石黒亮、中村義一:転写後調節、分子生物学イラストレイテッド第3版(田村隆明、山本雅編)、羊土社、p. 123-134 (2009)
  24. 藤原将寿、宮川伸、中村義一:核酸創薬の開発状況、「分子標的薬開発への挑戦」(岡野栄之ら編)、実験医学、27: 791-797 (2009)
  25. 金玲、中村義一:新しいRNA医薬 miRNAとRNAアプタマー、Bio Clinica, 24: 55-61 (2009)
  26. 宮川伸、藤原将寿、中村義一:RNA医薬、分子生物学イラストレイテッド第3版(田村隆明、山本雅編)、羊土社、p. 312-317 (2009)
  27. 藤原将寿、宮川伸、西山道久、中村義一:アプタマー、「核酸医薬の最前線」(和田猛 監修)、シーエムシー出版、p. 162-175 (2009)
  28. 岩川外史郎、中村義一:RNAアプタマーの開発と医薬品への応用、Medical Science Digest、35: 5-6 (2009)
  29. 石黒亮、中村義一:転写後調節、分子生物学イラストレイテッド第3版(田村隆明、山本雅編)、羊土社、p. 123-134 (2009)
  30. 宮川伸、藤原将寿、中村義一:RNA医薬、分子生物学イラストレイテッド第3版(田村隆明、山本雅編)、羊土社、p. 312-317 (2009)
  31. 藤原将寿、宮川伸、中村義一:核酸創薬の開発状況、「分子標的薬開発への挑戦」(岡野栄之ら編)、実験医学、27: 791-797 (2009)
  32. 金玲、中村義一:新しいRNA医薬 miRNAとRNAアプタマー、Bio Clinica, 24: 55-61 (2009)
  33. 藤原将寿、宮川伸、西山道久、中村義一:アプタマー、「核酸医薬の最前線」(和田猛 監修)、シーエムシー出版、p. 162-174 (2009)
  34. 岩川外史郎、中村義一:RNAアプタマーの開発と医薬品への応用、Medical Science Digest、35: 5-6 (2009)
  35. 石川百合子、藤原将寿、中村義一:RNAアプタマーの医薬品応用、炎症と免疫、16: 627-633 (2008)
  36. 倉橋洋史、中村義一:遺伝子発現、「タンパク質の事典」(猪飼篤ら編)、朝倉書店、 p. 151-158 (2008)
  37. 金玲、藤原将寿、中村義一:RNA医薬、「RNA研究の新知見と医療応用への展望」(林崎良英、安田純編)、実験医学、26: 1651-1656 (2008)
  38. 阿部智行、山崎聡子、中村義一:アプタマーを用いたバイオセンサー、「バイオセンサーの先端科学技術と応用」(民谷栄一 監修)、シーエムシー出版、52: 54-64 (2007)
  39. 宮川伸、藤原将寿、中村義一:アプタマー創薬、放射線生物研究、42: 312-328 (2007)
  40. 山崎聡子、阿部智行、中村義一:機能性RNAアプタマーの医療分野への展開、ケミカルエンジニヤリング、52: 527-533 (2007)
  41. 中村義一:翻訳研究のダイナミズム、「翻訳制御」(中村義一監修)、実験医学、25: 2-4 (2007)
  42. 遠藤慧、中村義一:SPRを用いたタンパク質ー核酸相互作用の解析法、実験医学「実験ハンドブックシリーズ」羊土社、205-209 (2007)>
  43. 藤原将寿、宮川伸、中村義一:アプタマー創薬、ファルマシア、42: 1232-1236 (2006)
  44. 中村義一、大内将司:「RNAと疾患」監修序文、分子細胞治療、5: 391-392 (2006)
  45. 倉橋洋史、中村義一:酵母においてプリオン説は証明された、科学、76: 1128-1133 (2006)
  46. 中村義一:「RNAと生命」編集序文、蛋白質核酸酵素、51: 2405-2406 (2006)
  47. 中村義一:桧舞台に躍り出たRNA、「RNAと生命」(中村義一編集)、蛋白質核酸酵素、51: 2409-2412 (2006)
  48. 宮川伸、藤原将寿、中村義一:アプタマー医薬、「RNAと生命」(中村義一編集)、蛋白質核酸酵素、51: 2521-2527 (2006)
  49. 中村義一:翻訳終結因子とプリオン、「RNAと生命」(中村義一編集)、蛋白質核酸酵素、51: 2574-2582 (2006)
  50. 藤原将寿、宮川伸、中村義一:アプタマー医薬品、BIO Clinica、21: 725-729 (2006)
  51. 藤原将寿、宮川伸、中村義一:核酸創薬、バイオテクノロジージャーナル、6:650-654 (2006)
  52. 大内将司:構造体として機能するRNA.実験医学、24: 800-804(2006)
  53. 中村義一:RNAは擬態する、科学、岩波書店、76: 500-506(2006)
  54. 中村義一:RNA科学概論、遺伝子医学MOOK「RNAと創薬」(中村義一 監修)、メディカルドゥ、23-30(2006)
  55. 中村義一:RNA抗体としてのポテンシャル、遺伝子医学MOOK「RNAと創薬」(中村義一 監修)、メディカルドゥ、39-46(2006)
  56. 大内将司:アプタマー工学、遺伝子医学MOOK「RNAと創薬」(中村義一 監修)メディカルドゥ、32-38(2006)
  57. 大内将司:リボザイム・テクノロジー、遺伝子医学MOOK「RNAと創薬」(中村義一 監修)、メディカルドゥ、143-151(2006)
  58. 望月潔隆、小黒明広、中村義一:翻訳開始因子(elF)の異常による癌化と創薬、遺伝子医学MOOK「RNAと創薬」(中村義一 監修)、メディカルドゥ、195-201(2006)
  59. 大内将司、中村義一:人工的な機能性核酸分子の創出、臨床化学、 34: 197-204. (2005)
  60. 中村義一:RNA入門、「RNA工学の最前線」(中村義一・大内将司 監修)、シーエムシー出版、1-6(2005)
  61. 大内将司:アプタマー概論、「RNA工学の最前線」(中村義一・大内将司 監修)、シーエムシー出版、139-154(2005)
  62. 小黒明広:翻訳開始因子に対するアプタマーによる制がん戦略、「RNA工学の最前線」(中村義一・大内将司 監修)、シーエムシー出版、155-166(2005)
  63. 和田猛、宮川伸:核酸医薬の安定化戦略、「RNA工学の最前線」(中村義一・大内将司 監修)、シーエムシー出版、238-249(2005)
  64. 中村義一:RNAとゲノム・特集にあたって、「RNAとゲノム」(中村義一編)、ゲノム医学、4: 360-361 (2004)
  65. 大内将司、中村義一:RNAとゲノム・概論、「RNAとゲノム」(中村義一編)、ゲノム医学、4: 365-370 (2004)
  66. 中村義一、塩見春彦:RNAルネッサンス、「躍進するRNA研究」(中村義一、塩見春彦編)、実験医学、22: 2368-2377 (2004)
  67. 小黒明広、中村義一:RNAアプタマーの応用展開、「躍進するRNA研究」(中村義一、塩見春彦編)、実験医学、22: 2529-2533 (2004)
  68. Colin G. Crist、小玉裕之、中村義一:RNAとプリオン、「躍進するRNA研究」(中村義一、塩見春彦編)、実験医学、22: 2573-2581(2004)
  69. 伊藤耕一:翻訳終結機構、「躍進するRNA研究」(中村義一、塩見春彦編)、実験医学、22: 2408-2412 (2004)
  70. 大内将司、中村義一:RNAのダイナミズム、「ヒトゲノム」(榊佳之他編)、Molecular Medicine、中山書店、pp. 118-129 (2004)
  71. 小黒明広、中村義一:遺伝子の働き、「生命科学」(柳田充弘、佐藤文彦、石川冬木編)、東京化学同人、pp. 87-95 (2004)
  72. 中村義一:ポストゲノムの主役へ、その多彩なはたらき、「RNAがわかる」(中村義一編)、羊土社、16-27 (2003)
  73. 中村義一:RNA科学の潮流、「RNAの細胞生物学」(中村義一、坂本博編)、蛋白質・核酸・酵素、共立出版、48: 319-328 (2003)
  74. 伊藤耕一、中村義一:翻訳終結の分子機構:いくつかのtRNA擬態狂騒曲への個人的視点、「RNAの細胞生物学」(中村義一、坂本博編)、蛋白質・核酸・酵素、共立出版、48: 329-327 (2003)
  75. 和田美紀、中村義一:ニューモシスチス・カリニゲノムの可塑性、現代医療、34 (5): 1061-1065 (2002)
  76. 中村義一:ゲノミクスとプロテオミクスを結ぶRNA情報ネットワーク(特集監修)、実験医学、20: 1382-1387 (2002)
  77. 大津敬、小黒明広、神津知子:RNA医工学、実験医学 20:1415-1420(2002)
  78. 中屋敷徹、原英之、中村義一:酵母プリオンの分子生物学、医学のあゆみ、203 (10): 938-943(2002)
  79. 伊藤耕一、 豊田友彦、中村義一:翻訳因子とtRNA擬態、蛋白質・核酸・酵素、46: 1645-1650 (2001)
  80. 中屋敷徹、中村義一:酵母プリオンの分子生物学、ウィルス、51: 171-176 (2001)
  81. 伊藤耕一、中村義一:tRNA擬態、「RNA研究の最前線」(志村令郎、渡辺公綱編)、シュプリンガー・フェアラーク、p. 83-91 (2000)
  82. 松藤千弥、藤原俊伸、中村義一:リコーディング、「RNA研究の最前線」(志村令郎、渡辺公綱編)、シュプリンガー・フェアラーク、p. 139-149 (2000)
  83. 田中りつこ、中村義一:snoRNA、「RNA研究の最前線」(志村令郎、渡辺公綱編)、シュプリンガー・フェアラーク、p. 118-126 (2000)
  84. 伊藤耕一、中村義一:終止コドンを識別するペプチドアンチコドンの発見、実験医学、18: 1099-1102 (2000)
  85. 大津敬、小黒明広、中村義一:RNA医工学、「ゲノム医科学とこれからのゲノム医療」(中村祐輔、浅野茂隆、新井賢一編)、羊土社、実験医学、18: 1726-1734 (2000)
  86. 中村義一:分子擬態、生命誌ーBiohistory、27:12-13(2000)
  87. 中村義一::ミクロの世界の擬態、「プロテオーム研究とシグナル蛋白ドメイン」(竹縄忠臣編)、羊土社、実験医学、18:2444-2450 (2000)